6
Views
1
CrossRef citations to date
0
Altmetric
Review

Cutaneous melanocytomas: a conceptual cluster of atypical and indolent melanocytic neoplasms

, , &
Pages 185-194 | Published online: 10 Jan 2014

References

  • Smoller BR. Histologic criteria for diagnosing primary cutaneous malignant melanoma. Mod. Pathol. 19(Suppl. 2), S34–S40 (2006).
  • Farmer ER, Gonin R, Hanna MP. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum. Pathol. 27(6), 528–531 (1996).
  • Grant-Kels JM, Bason ET, Grin CM. The misdiagnosis of malignant melanoma. J. Am. Acad. Dermatol. 40(4), 539–548 (1999).
  • Brochez L, Verhaeghe E, Grosshans E et al. Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J. Pathol. 196(4), 459–466 (2002).
  • Cook MG. Diagnostic pitfalls with melanocytic tumours. Curr. Diag. Pathol. 10, 463–472 (2004).
  • Quatresooz P, Piérard-Franchimont C, Piérard GE. Highlighting the immunohistochemical profile of melanocytomas: review. Oncol. Rep. 19(6), 1367–1372 (2008).
  • Darier J, Civatte A. Naevus ou naevo-carcinoma chez un nourisson. Bull. Soc. Franc. Derm. Syph. 21, 61–63 (1910).
  • Spitz S. Melanomas of childhood. Am. J. Pathol. 24(3), 591–609 (1948).
  • Spitz S. Cutaneous tumors of childhood. Disparity between clinical behavior and histologic appearance. J. Am. Med. Womens Assoc. 6(6), 209–219 (1951).
  • Orchard DC, Dowling JP, Kelly JW. Spitz naevi misdiagnosed histologically as melanoma: prevalence and clinical profile. Australas. J. Dermatol. 38(1), 12–14 (1997).
  • Walsh N, Crotty K, Palmer A, McCarthy S. Spitz nevus versus Spitzoid malignant melanoma: an evaluation of the current distinguishing histopathologic criteria. Hum. Pathol. 29(10), 1105–1112 (1998).
  • Barnhill RL, Argenyi ZB, From L et al. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum. Pathol. 30(5), 513–520 (1999).
  • Spatz A, Calonje E, Handfield-Jones S, Barnhill RL. Spitz tumors in children: a grading system for risk stratification. Arch. Dermatol. 135(3), 282–285 (1999).
  • Gurbuz Y, Apaydin R, Muezzinoglu B, Buyukbabani N. A current dilemma in histopathology: atypical Spitz tumor or Spitzoid melanoma? Pediatr. Dermatol. 19(2), 99–102 (2002).
  • Mones JM, Ackerman AB. ‘Atypical’ Spitz’s nevus, ‘malignant’ Spitz’s nevus, and ‘metastasizing’ Spitz’s nevus: a critique in historical perspective of three concepts flawed fatally. Am. J. Dermatopathol. 26(4), 310–333 (2004).
  • Barnhill RL. The Spitzoid lesion: rethinking Spitz tumors, atypical variants, ‘Spitzoid melanoma’ and risk assessment. Mod. Pathol. 19(Suppl. 2), S21–S33 (2006).
  • Lee JB. Spitz nevus versus melanoma: limitation of the diagnostic methodology exposed. Eur. J. Dermatol. 16(3), 223–224 (2006).
  • Mooi WJ, Krausz T. Spitz nevus versus Spitzoid melanoma: diagnostic difficulties, conceptual controversies. Adv. Anat. Pathol. 13(4), 147–156 (2006).
  • Sepehr A, Chao E, Trefrey B et al. Long-term outcome of Spitz-type melanocytic tumors. Arch. Dermatol. 147(10), 1173–1179 (2011).
  • Bourguignon JP, Piérard GE, Ernould C et al. Effects of human growth hormone therapy on melanocytic naevi. Lancet 341(8859), 1505–1506 (1993).
  • Ball NJ, Golitz LE. Melanocytic nevi with focal atypical epithelioid cell components: a review of seventy-three cases. J. Am. Acad. Dermatol. 30(5 Pt 1), 724–729 (1994).
  • Paquet P, Arrese JE, Greimers R et al. Eruptive speckled melanocytic nevi following drug-induced toxic epidermal necrolysis. Eur. J. Dermatol. 5, 379–382 (1995).
  • Piérard GE, Piérard-Franchimont C, Nikkels A, Nikkels-Tassoudji N, Arrese JE, Bourguignon JP. Naevocyte triggering by recombinant human growth hormone. J. Pathol. 180(1), 74–79 (1996).
  • Sabroe RA, Vaingankar NV, Rigby HS, Peachey RD. Agminate Spitz naevi occurring in an adult after the excision of a solitary Spitz naevus – report of a case and review of the literature. Clin. Exp. Dermatol. 21(3), 197–200 (1996).
  • Collina G, Deen S, Cliff S, Jackson P, Cook MG. Atypical dermal nodules in benign melanocytic naevi. Histopathology 31(1), 97–101 (1997).
  • Onsun N, Saraçoglu S, Demirkesen C, Kural YB, Atilganoglu U. Eruptive widespread Spitz nevi: can pregnancy be a stimulating factor? J. Am. Acad. Dermatol. 40(5 Pt 2), 866–867 (1999).
  • Reginster MA, Pierard-Franchimont C, Piérard GE, Quatresooz P. Molecular dermatopathology in malignant melanoma. Dermatol. Res. Pract. 2012, 684032 (2012).
  • Piérard GE, Piérard-Franchimont C, Delvenne P. Streamlining molecular pathobiology of malignant melanoma. In: Essentials of Diagnostic Pathology/Molecular Pathology. Hoefler G, van Krieken H, Hummel M, Stanta G (Eds). Springer Verlag, Berlin, Heidelberg, Germany (In Press).
  • Turhan T, Oner K, Yurtseven T, Akalin T, Ovul I. Spinal meningeal melanocytoma. Report of two cases and review of the literature. J. Neurosurg. 100(3 Suppl. Spine), 287–290 (2004).
  • O’Brien DF, Crooks D, Mallucci C et al. Meningeal melanocytoma. Childs. Nerv. Syst. 22(6), 556–561 (2006).
  • Park SI, Cho KO. Dermal melanocytoma-acanthoma in an adult mixed breed dog. Jpn J. Vet. Res. 58(3-4), 165–169 (2010).
  • Liu W, Bennett M, Helm T. Canine melanoma: a comparison with human pigmented epithelioid melanocytoma. Int. J. Dermatol. 50(12), 1542–1545 (2011).
  • Semin MO, Serra F, Mahe V, Deviers A, Regnier A, Raymond-Letron I. Choroidal melanocytoma in a cat. Vet. Ophthalmol. 14(3), 205–208 (2011).
  • Ainsworth AM, Folberg R, Reed RJ, Clark W. Melanocytic nevi, melanocytomas, melanocytic dysplasias, and uncommon forms of melanoma. In: Human Malignant Melanoma, Clinical Oncology Monographs. Clark WH, Goldman KI, Mastrangelo MJ (Eds). Grune & Stratton, New York, NY, USA, 167–208 (1979).
  • Fraitag S, Vignon-Pennamen MD. Spitz tumor and pigmented epithelioid melanocytoma: new nosological frameworks for commonly ill-defined tumors. Ann. Dermatol. Venereol. 136(2), 133–144 (2009).
  • Mandal RV, Murali R, Lundquist KF et al. Pigmented epithelioid melanocytoma: favorable outcome after 5-year follow-up. Am. J. Surg. Pathol. 33(12), 1778–1782 (2009).
  • Quatresooz P, Arrese JE, Pierard-Franchimont C, Pierard GE. Immunohistochemical aid at risk stratification of melanocytic neoplasms. Int. J. Oncol. 24(1), 211–216 (2004).
  • Piérard GE, Al Rustom K. Dysplastic nevi and the concept of triggered melanocytic system. Em. Med. J. 7, 3–6 (1989).
  • Aktürk AS, Bilen N, Bayrämgürler D, Demirsoy EO, Erdogan S, Kiran R. Dermoscopy is a suitable method for the observation of the pregnancy-related changes in melanocytic nevi. J. Eur. Acad. Dermatol. Venereol. 21(8), 1086–1090 (2007).
  • Tronnier M, Wolff HH. UV-irradiated melanocytic nevi simulating melanoma in situ. Am. J. Dermatopathol. 17(1), 1–6 (1995).
  • Brozyna A, Zbytek B, Granese J, Carlson JA, Ross J, Slominski A. Mechanism of UV-related carcinogenesis and its contribution to nevi/melanoma. Expert Rev. Dermatol. 2(4), 451–469 (2007).
  • Raimondi S, Sera F, Gandini S et al. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int. J. Cancer 122(12), 2753–2760 (2008).
  • Gandini S, Sera F, Cattaruzza MS et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur. J. Cancer 41(1), 45–60 (2005).
  • Bataille V, Boniol M, De Vries E et al. A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur. J. Cancer 41(14), 2141–2149 (2005).
  • Gandini S, Sera F, Cattaruzza MS et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur. J. Cancer 41(1), 28–44 (2005).
  • Falchi M, Spector TD, Perks U, Kato BS, Bataille V. Genome-wide search for nevus density shows linkage to two melanoma loci on chromosome 9 and identifies a new QTL on 5q31 in an adult twin cohort. Hum. Mol. Genet. 15(20), 2975–2979 (2006).
  • Zhu G, Montgomery GW, James MR et al. A genome-wide scan for naevus count: linkage to CDKN2A and to other chromosome regions. Eur. J. Hum. Genet. 15(1), 94–102 (2007).
  • Chang YM, Newton-Bishop JA, Bishop DT et al. A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. Int. J. Cancer 124(2), 420–428 (2009).
  • Pérez-Gómez B, Aragonés N, Gustavsson P, Lope V, López-Abente G, Pollán M. Do sex and site matter? Different age distribution in melanoma of the trunk among Swedish men and women. Br. J. Dermatol. 158(4), 766–772 (2008).
  • Uhoda I, Quatresooz P, Fumal I, Nikkels AF, Piérard-Franchimont C, Piérard GE. Updating trends in cutaneous cancers in south-east Belgium. Oncol. Rep. 12(1), 111–114 (2004).
  • Zembowicz A, Carney JA, Mihm MC. Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am. J. Surg. Pathol. 28(1), 31–40 (2004).
  • Antony FC, Sanclemente G, Shaikh H, Trelles AS, Calonje E. Pigment synthesizing melanoma (so-called animal type melanoma): a clinicopathological study of 14 cases of a poorly known distinctive variant of melanoma. Histopathology 48(6), 754–762 (2006).
  • Ludgate MW, Fullen DR, Lee J et al. Animal-type melanoma: a clinical and histopathological study of 22 cases from a single institution. Br. J. Dermatol. 162(1), 129–136 (2010).
  • Quatresooz P, Pierard-Franchimont C, Pierard GE; Mosan Study Group Of Pigmented Tumors. Molecular histology on the diagnostic cutting edge between malignant melanomas and cutaneous melanocytomas (Review). Oncol. Rep. 22(6), 1263–1267 (2009).
  • Alonso SR, Ortiz P, Pollán M et al. Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study. Am. J. Pathol. 164(1), 193–203 (2004).
  • Bergman R, Dromi R, Trau H, Cohen I, Lichtig C. The pattern of HMB-45 antibody staining in compound Spitz nevi. Am. J. Dermatopathol. 17(6), 542–546 (1995).
  • Kanter-Lewensohn L, Hedblad MA, Wejde J, Larsson O. Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas. Mod. Pathol. 10(9), 917–920 (1997).
  • Kapur P, Selim MA, Roy LC, Yegappan M, Weinberg AG, Hoang MP. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis. Mod. Pathol. 18(2), 197–204 (2005).
  • Orlandi A, Costantini S, Campione E et al. Relation between animal-type melanoma and reduced nuclear expression of glutathione S-transferase pi. Arch. Dermatol. 145(1), 55–62 (2009).
  • Paquet P, Piérard GE. Glutathione-S-transferase pi expression in toxic epidermal necrolysis: a marker of putative oxidative stress in keratinocytes. Skin Pharmacol. Physiol. 20(2), 66–70 (2007).
  • Quatresooz P, Piérard GE. Immunohistochemical investigation of α1 (IV) and α5 (IV) collagen chains in a broad spectrum of melanocytic tumours. Melanoma Res. 15(3), 161–168 (2005).
  • Piérard GE, Piérard-Franchimont C. HOX gene aberrant expression in skin melanoma. J. Skin Cancer 2012, 707260 (2012).
  • Abásolo A, Vargas MT, Ríos-Martín JJ, Trigo I, Arjona A, González-Cámpora R. Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax-embedded tissues and imprint-cytology specimens. Clin. Exp. Dermatol. 37(8), 838–843 (2012).
  • de Klein A, Koopmans AE, Kilic E. Multicolor FISH with improved sensitivity and specificity in the diagnosis of malignant melanoma. Expert Rev. Mol. Diagn. 12(7), 683–685 (2012).
  • Gammon B, Gerami P. Fluorescence in situ hybridization for ambiguous melanocytic tumors. Histol. Histopathol. 27(12), 1539–1542 (2012).
  • Kiuru M, Patel RM, Busam KJ. Desmoplastic melanocytic nevi with lymphocytic aggregates. J. Cutan. Pathol. 39(10), 940–944 (2012).
  • Pennacchia I, Garcovich S, Gasbarra R, Leone A, Arena V, Massi G. Morphological and molecular characteristics of nested melanoma of the elderly (evolved lentiginous melanoma). Virchows Arch. 461(4), 433–439 (2012).
  • Requena C, Rubio L, Traves V et al. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and Spitzoid melanoma. Histopathology 61(5), 899–909 (2012).
  • Ali L, Helm T, Cheney R et al. Correlating array comparative genomic hybridization findings with histology and outcome in Spitzoid melanocytic neoplasms. Int. J. Clin. Exp. Pathol. 3(6), 593–599 (2010).
  • Gerami P, Pouryazdanparast P, Vemula S, Bastian BC. Molecular analysis of a case of nevus of ota showing progressive evolution to melanoma with intermediate stages resembling cellular blue nevus. Am. J. Dermatopathol. 32(3), 301–305 (2010).
  • Vanison C, Tanna N, Murthy AS. Comparative genomic hybridization for the diagnosis of melanoma. Eur. J. Plast. Surg. 33(1), 45–48 (2010).
  • de la Fouchardière A, Vergier B. Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH). Ann. Pathol. 31, S115–S116 (2011).
  • Abraham RM, Ming ME, Elder DE, Xu X. An atypical melanocytic lesion without genomic abnormalities shows locoregional metastasis. J. Cutan. Pathol. 39(1), 21–24 (2012).
  • Held L, Metzler G, Eigentler TK et al. Recurrent nodules in a periauricular plaque-type blue nevus with fatal outcome. J. Cutan. Pathol. 39(12), 1088–1093 (2012).
  • Yeh I, Vemula SS, Mirza SA, McCalmont TH. Neurofibroma-like spindle cell melanoma: CD34 fingerprint and CGH for diagnosis. Am. J. Dermatopathol. 34(6), 668–670 (2012).
  • Lohmann CM, Coit DG, Brady MS, Berwick M, Busam KJ. Sentinel lymph node biopsy in patients with diagnostically controversial Spitzoid melanocytic tumors. Am. J. Surg. Pathol. 26(1), 47–55 (2002).
  • Pierard GE, Pierard-Franchimont C. The proliferative activity of cells of malignant melanomas. Am. J. Dermatopathol. 6, 317–323 (1984).
  • Piérard GE, Piérard-Franchimont C. Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas. Eur. J. Cancer 33(11), 1888–1892 (1997).
  • Banerjee SS, Harris M. Morphological and immunophenotypic variations in malignant melanoma. Histopathology 36(5), 387–402 (2000).
  • Li LX, Crotty KA, McCarthy SW, Palmer AA, Kril JJ. A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions. Am. J. Dermatopathol. 22(6), 489–495 (2000).
  • Bergman R, Malkin L, Sabo E, Kerner H. MIB-1 monoclonal antibody to determine proliferative activity of Ki-67 antigen as an adjunct to the histopathologic differential diagnosis of Spitz nevi. J. Am. Acad. Dermatol. 44(3), 500–504 (2001).
  • Fecher LA, Cummings SD, Keefe MJ, Alani RM. Toward a molecular classification of melanoma. J. Clin. Oncol. 25(12), 1606–1620 (2007).
  • Ohsie SJ, Sarantopoulos GP, Cochran AJ, Binder SW. Immunohistochemical characteristics of melanoma. J. Cutan. Pathol. 35(5), 433–444 (2008).
  • Quatresooz P, Pierard GE, Pierard-Franchimont C; Mosan Study Group of Pigmented Tumors. Molecular pathways supporting the proliferation staging of malignant melanoma (review). Int. J. Mol. Med. 24(3), 295–301 (2009).
  • Quatresooz P, Pierard-Franchimont C, Paquet P, Pierard GE. Angiogenic fast-growing melanomas and their micrometastases. Eur. J. Dermatol. 20(3), 302–307 (2010).
  • Gaudi S, Messina JL. Molecular bases of cutaneous and uveal melanomas. Patholog. Res. Int. doi:10.4061/2011/159421 (2011) (Epub ahead of print).
  • Quatresooz P, Piérard GE. Malignant melanoma: from cell kinetics to micrometastases. Am. J. Clin. Dermatol. 12(2), 77–86 (2011).
  • Piérard GE. Cell proliferation in malignant melanoma: relationship with neoplastic progression. Int. Schol. Res. Network Dermatol. doi:10.5402/2012/828146 (2012) (Epub ahead of print).
  • Richmond-Sinclair NM, Lee E, Cummings MC et al. Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53, and p16 immunostaining in cutaneous melanomas. Melanoma Res. 18(5), 336–345 (2008).
  • Piérard GE, Piérard-Franchimont C, Hermanns-Lê T, Delvenne P. Cutaneous malignant melanoma: one single disease? Rev. Med. Liege. 67(9), 458–460 (2012).
  • Piérard GE, Piérard-Franchimont C, Reginster MA, Quatresooz P. Smouldering malignant melanoma and metastatic dormancy. An update and review. Derm. Res. Prac. 2012, 461278 (2012).
  • Piérard GE, Piérard-Franchimont C, Delvenne P. Malignant melanoma and its stromal nonimmune microecosystem. J. Oncol. doi:10.1155/2012/584219 (2012) (Epub ahead of print).
  • Mangini J, Li N, Bhawan J. Immunohistochemical markers of melanocytic lesions: a review of their diagnostic usefulness. Am. J. Dermatopathol. 24(3), 270–281 (2002).
  • Hussein MR, Haemel AK, Wood GS. Apoptosis and melanoma: molecular mechanisms. J. Pathol. 199(3), 275–288 (2003).
  • Vollmer RT. Use of Bayes rule and MIB-1 proliferation index to discriminate Spitz nevus from malignant melanoma. Am. J. Clin. Pathol. 122(4), 499–505 (2004).
  • Heymans O, Blacher S, Brouers F, Piérard GE. Fractal quantification of the microvasculature heterogeneity in cutaneous melanoma. Dermatology (Basel) 198(2), 212–217 (1999).
  • Quatresooz P, Piérard GE, Piérard-Franchimont C, Humbert P, Piérard S. Spectral analysis of the microvasculature of primary cutaneous melanoma. Pathol. Biol. 60(2), 149–153 (2012).
  • Bayer-Garner IB, Hough AJ Jr, Smoller BR. Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness. Mod. Pathol. 12(8), 770–774 (1999).
  • Cockerell CJ, Sonnier G, Kelly L, Patel S. Comparative analysis of neovascularization in primary cutaneous melanoma and Spitz nevus. Am. J. Dermatopathol. 16(1), 9–13 (1994).
  • Piérard-Franchimont C, Henry F, Heymans O, Piérard GE. Vascular retardation in dormant growth-stunted malignant melanomas. Int. J. Mol. Med. 4(4), 403–406 (1999).
  • Diaz-Cascajo C, Borghi S, Weyers W. Angiomatoid Spitz nevus: a distinct variant of desmoplastic Spitz nevus with prominent vasculature. Am. J. Dermatopathol. 22(2), 135–139 (2000).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.